Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management (Q37889470)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Gastrointestinal symptoms in Parkinson disease: clinical aspects and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management (English)

1 reference

10.1017/S0317167100012099

DOI

https://api.crossref.org/works/10.1017/S0317167100012099

4 December 2024

1 reference

D. Salat-Foix

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21672695

4 December 2024

C. N. Andrews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21672695

4 December 2024

J. Meddings

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21672695

4 December 2024

O. Suchowersky

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21672695

4 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21672695

4 December 2024

publication date

1 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

July 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21672695

full work available at URL

4 December 2024

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1E6E15627552D8D796B0ECB07F738FCD/S0317167100012099a.pdf/div-class-title-gastrointestinal-symptoms-in-parkinson-disease-clinical-aspects-and-management-div.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21672695

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0317167100012099

4 December 2024

1 reference

10.1017/S0317167100012099

DOI

https://api.crossref.org/works/10.1017/S0317167100012099

Canadian Journal of Neurological Sciences

4 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

557-564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Functional magnetic stimulation in constipation associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Irregular gastrointestinal drug absorption in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Does levodopa improve swallowing dysfunction in Parkinson's disease patients?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Drooling of saliva: a review of the etiology and management options

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

A descriptive analysis of studies on behavioural treatment of drooling (1970-2005).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Randomized controlled trial of biofeedback for fecal incontinence

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Long-term results with cisapride in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Pain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Swallowing disorders in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Gastrointestinal symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

A randomized trial of botulinum toxin A for treatment of drooling

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Impact of drooling in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

The relationship between quality of life and swallowing in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Practice parameters and technology assessments: what they are, what they are not, and why you should care

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Bowel movement frequency in late-life and incidental Lewy bodies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Environmental, life-style, and physical precursors of clinical Parkinson?s disease: recent findings from the Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Neurogenic colorectal and pelvic floor dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Effects of therapy for dysphagia in Parkinson's disease: systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Behavioural treatment of the dyssynergic defecation in chronically constipated elderly patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Swallowing problems in Parkinson disease: frequency and clinical correlates.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Gum chewing improves swallow frequency and latency in Parkinson patients: A preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Microbial endocrinology as a basis for improved L-DOPA bioavailability in Parkinson's patients treated for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Six years of experience with sacral nerve stimulation for fecal incontinence

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Neural control of the gastrointestinal tract: implications for Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Gastric emptying time and gastric motility in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Medical records documentation of constipation preceding Parkinson disease: A case-control study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Bladder and bowel dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100012099

1 reference

7 January 2021

Non-motor symptoms: identification and management

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Constipation in parkinson's disease: Objective assessment and response to psyllium

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Gastrointestinal dysfunction in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Prevalence and definition of drooling in Parkinson's disease: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Videofluorographic study of swallowing in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Botulinum toxin type-A in therapy of patients with anismus

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

A constipation scoring system to simplify evaluation and management of constipated patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Gastrointestinal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Bowel movement frequency in late-life and substantia nigra neuron density at death

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Manometric abnormalities of the oesophagus in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Excess burden of constipation in Parkinson's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Lost in a jungle of evidence: we need a compass

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Delayed gastric emptying: whom to test, how to test, and what to do

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100012099

7 January 2021

10.1017/S0317167100012099

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21672695%20AND%20SRC:MED&resulttype=core&format=json